Finally, FNIPs also enhance the binding of Hsp90 to its inhibitors such as ganetespib (GB); therefore, overexpression of FNIPs in specific tumours can be an indicator of their response to Hsp90 inhibitors. Here, HSP90AA1 is linked to neoplasm.